Company profile
Highland Biosciences Ltd is a UK company with status active founded in 2006 based in Scotland.
Financial period: 31 Dec 2023 to 30 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Dec 2021 to 31 Jan 2022
Traumatic injuries are a major unmet clinical need and the leading cause of death and disability among young people around the world. Trauma treatment and management is very complex, costly and resource-intense. It is a fast-moving environment where clinicians constantly seek the best treatment to manage and stabilise very sick patients. In these patients...
1 Jun 2020 to 28 Feb 2022
no public description
1 Nov 2017 to 30 Jun 2023
Traumatic injuries are a major unmet clinical need and the leading cause of death and disability among young people around the world. Trauma treatment and management is very complex, costly and resource-intense. It is a fast-moving environment where clinicians constantly seek the best treatment to manage and stabilise very sick patients. In these patients...
1 Mar 2016 to 30 Nov 2016
Handheld Biosensor for the stratification of patients at risk of Venous Thromboembolism (VTE) This project will demonstrate the capability of a new diagnostic biosensor that provides for the first time viscoelastomeric coagulation data to stratify patients by risk of blood clot formation. The project will pilot the technology which can be applied to impro...
1 Aug 2014 to 30 Nov 2014
This project will examine the use of novel flexible piezoelectric materials in the fabrication of the next generation of low energy devices for diagnosing and managing diseases such as type 2 diabetes. The approach will study the process of manufacturing state of the art flexible piezoelectric devices and develop a feasible manufacturing route to market. ...
1 Jul 2014 to 30 Sep 2015
This project will demonstrate the feasibility of applying a sophisticated analysis method for the detection of clinically relevant blood clotting defects in patients to an emerging diagnostic sensor platform technology that can be applied to improve outcomes in many high mortality conditions, particularly common amongst the ageing population. Thrombotic d...
1 Aug 2013 to 31 Jul 2014
This project will demonstrate the feasibility of combining an innovative low-energy light harvesting technology with an emerging sensor platform to deliver ground breaking solutions that can be developed into innovative products in many diverse application areas. The project, which is a collaboration between Sharp Laboratories of Europe and Highland Biosc...
1 Sep 2011 to 28 Feb 2014
Since its inception in 2007, HBL has delivered a breakthrough bio-diagnostic platform covered by international patents: a foundation for a range of high performance life science products. This development has not gone unnoticed with interest from major distributors from around the globe, particularly the US and Japan. The route to market relies upon the a...
1 Jun 2010 to 31 May 2011
Awaiting Public Summary
1 Jun 2010 to 31 May 2011
Awaiting Public Summary
